DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER

Clinical trial NCT07690540 · RECRUITING

Trial details

NCT number: NCT07690540
Sponsor: European Institute of Oncology
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Endometrial Cancer Immune Checkpoint Inhibitors

Start date: 2026-04-14
Primary completion: 2029-04-01
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.